FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015774448> ?p ?o ?g. }

• W3015774448 endingPage "331" @default.
• W3015774448 startingPage "322" @default.
• W3015774448 abstract "Despite optimal treatment, patients affected by non-muscle invasive bladder cancer (NMIBC) suffer from high risk of recurrence and progression. Intravescical device assisted therapies such as radiofrequency induced thermochemotherapeutic effect (RITE) and electromotive drug administration (EMDA) have shown promising effect in enhancing the effect of intravescical chemotherapies. The aim of the study was to assess clinical outcomes of these two devices in non-muscle invasive bladder cancer.A systematic literature review was performed in December 2019 using the Medline, Embase, and Web of Science databases. Only articles published in the last 10 years were considered (2009-2019). The articles were selected using the following keywords association: bladder cancer AND EMDA' AND synergo AND hyperchemotherapy AND electromotive drug administration, AND radiofrequency induced thermochemotherapeutic AND RITE.We found 16 studies published in the last ten years regarding the efficacy of RITE (12 studies) and EMDA (4 studies) in the treatment of NMIBC. Both RITE and EMDA showed promising results in the treatment of intermediate and high risk NMIBC as well as in patients affected by recurrent BCa after BCG failure. In high-risk BCG naïve NMIBC patients treated with EMDA recurrence and progression rates were 68% and 95%, respectively. Considering RITE, recurrence and progression range rates were 43%-88% and 62%-97%, respectively. Discordance results were reported regarding its effect on patients with carcinoma in situ. However, only few studies could be compared since differences exist regarding inclusion criteria with high patients' heterogeneity. Considering recurrence after BCG, recurrence and progression range rates were 29%-29.2% and 62%-83% for RITE and 25% and 75% for EMDA, respectively.Delivery of intravescical hyperthermia seems to enhance the normal effect of intravescical chemotherapy instillation. Although prospective trials supported its effect on both BCG naïve and BCG failure patients, data are urgently required to validate these findings and to understand its effect on patients with carcinoma in situ.3." @default.
• W3015774448 created "2020-04-17" @default.
• W3015774448 creator A5003986269 @default.
• W3015774448 creator A5004532044 @default.
• W3015774448 creator A5012396827 @default.
• W3015774448 creator A5020529503 @default.
• W3015774448 creator A5023199834 @default.
• W3015774448 creator A5023899260 @default.
• W3015774448 creator A5031303345 @default.
• W3015774448 creator A5038866794 @default.
• W3015774448 creator A5040674932 @default.
• W3015774448 creator A5062997136 @default.
• W3015774448 creator A5083351538 @default.
• W3015774448 creator A5091337359 @default.
• W3015774448 date "2020-05-01" @default.
• W3015774448 modified "2023-10-13" @default.
• W3015774448 title "The role of device-assisted therapies in the management of non-muscle invasive bladder cancer: A systematic review" @default.
• W3015774448 cites W1509250581 @default.
• W3015774448 cites W1976407576 @default.
• W3015774448 cites W1978510140 @default.
• W3015774448 cites W1984253027 @default.
• W3015774448 cites W1986706406 @default.
• W3015774448 cites W2002045993 @default.
• W3015774448 cites W2017306423 @default.
• W3015774448 cites W2033649861 @default.
• W3015774448 cites W2035021864 @default.
• W3015774448 cites W2043488200 @default.
• W3015774448 cites W2044903247 @default.
• W3015774448 cites W2081006498 @default.
• W3015774448 cites W2084024470 @default.
• W3015774448 cites W2084204019 @default.
• W3015774448 cites W2085269836 @default.
• W3015774448 cites W2094764750 @default.
• W3015774448 cites W2110599321 @default.
• W3015774448 cites W2127315335 @default.
• W3015774448 cites W2134833483 @default.
• W3015774448 cites W2140516194 @default.
• W3015774448 cites W2155977349 @default.
• W3015774448 cites W2277438627 @default.
• W3015774448 cites W2305052472 @default.
• W3015774448 cites W2325921426 @default.
• W3015774448 cites W2345595560 @default.
• W3015774448 cites W2756190798 @default.
• W3015774448 cites W2765730870 @default.
• W3015774448 cites W2772208841 @default.
• W3015774448 cites W2781525129 @default.
• W3015774448 cites W2893171711 @default.
• W3015774448 cites W2903162255 @default.
• W3015774448 cites W2904555583 @default.
• W3015774448 cites W2976295763 @default.
• W3015774448 cites W2991616458 @default.
• W3015774448 cites W3011470625 @default.
• W3015774448 cites W4242445503 @default.
• W3015774448 cites W4376454100 @default.
• W3015774448 doi "https://doi.org/10.1016/j.purol.2020.03.005" @default.
• W3015774448 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32279953" @default.
• W3015774448 hasPublicationYear "2020" @default.
• W3015774448 type Work @default.
• W3015774448 sameAs 3015774448 @default.
• W3015774448 citedByCount "7" @default.
• W3015774448 countsByYear W30157744482020 @default.
• W3015774448 countsByYear W30157744482022 @default.
• W3015774448 countsByYear W30157744482023 @default.
• W3015774448 crossrefType "journal-article" @default.
• W3015774448 hasAuthorship W3015774448A5003986269 @default.
• W3015774448 hasAuthorship W3015774448A5004532044 @default.
• W3015774448 hasAuthorship W3015774448A5012396827 @default.
• W3015774448 hasAuthorship W3015774448A5020529503 @default.
• W3015774448 hasAuthorship W3015774448A5023199834 @default.
• W3015774448 hasAuthorship W3015774448A5023899260 @default.
• W3015774448 hasAuthorship W3015774448A5031303345 @default.
• W3015774448 hasAuthorship W3015774448A5038866794 @default.
• W3015774448 hasAuthorship W3015774448A5040674932 @default.
• W3015774448 hasAuthorship W3015774448A5062997136 @default.
• W3015774448 hasAuthorship W3015774448A5083351538 @default.
• W3015774448 hasAuthorship W3015774448A5091337359 @default.
• W3015774448 hasConcept C121608353 @default.
• W3015774448 hasConcept C126322002 @default.
• W3015774448 hasConcept C126894567 @default.
• W3015774448 hasConcept C143998085 @default.
• W3015774448 hasConcept C2777661416 @default.
• W3015774448 hasConcept C2778220009 @default.
• W3015774448 hasConcept C2780352672 @default.
• W3015774448 hasConcept C71924100 @default.
• W3015774448 hasConceptScore W3015774448C121608353 @default.
• W3015774448 hasConceptScore W3015774448C126322002 @default.
• W3015774448 hasConceptScore W3015774448C126894567 @default.
• W3015774448 hasConceptScore W3015774448C143998085 @default.
• W3015774448 hasConceptScore W3015774448C2777661416 @default.
• W3015774448 hasConceptScore W3015774448C2778220009 @default.
• W3015774448 hasConceptScore W3015774448C2780352672 @default.
• W3015774448 hasConceptScore W3015774448C71924100 @default.
• W3015774448 hasIssue "6" @default.
• W3015774448 hasLocation W30157744481 @default.
• W3015774448 hasLocation W30157744482 @default.
• W3015774448 hasOpenAccess W3015774448 @default.
• W3015774448 hasPrimaryLocation W30157744481 @default.
• W3015774448 hasRelatedWork W1979321249 @default.

• next